Related Experiment Video
Updated: May 31, 2026
05:15
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
Virus-like particles for antigen delivery at mucosal surfaces.
1Center for Vaccine Research, Department of Microbiology and Molecular Genetics, University of Pittsburgh, PA, USA.
Current Topics in Microbiology and Immunology
|July 12, 2011
Summary
Virus-like particles (VLPs) offer a novel vaccine approach, mimicking viruses without replication. This review explores VLPs for mucosal vaccines targeting respiratory, urogenital, and gastrointestinal infections.
Area of Science:
- Immunology
- Vaccinology
- Biotechnology
Background:
- Virus-like particles (VLPs) are emerging as a promising vaccine platform.
- VLPs self-assemble from viral structural proteins, resembling native viruses but lacking genetic material, thus preventing replication.
- They effectively engage the immune system, stimulating both humoral and cellular responses.
Purpose of the Study:
- To review the advancements in VLP technology for vaccine development.
- To discuss the application of VLPs in mucosal vaccination strategies.
- To highlight VLP potential against viruses entering through respiratory, urogenital, and gastrointestinal tracts.
Main Methods:
- Literature review of VLP vaccine development.
- Analysis of VLP immunogenicity and safety profiles.
- Evaluation of VLP delivery systems for mucosal surfaces.
Main Results:
- VLPs represent a safe and effective alternative to traditional vaccines.
- Mucosal vaccination using VLPs shows potential for various viral pathogens.
- VLP technology is advancing for practical vaccine applications.
Conclusions:
- VLPs are a versatile platform for developing next-generation vaccines.
- Targeting mucosal surfaces with VLPs offers a new route for immunization.
- Further research into VLP-based mucosal vaccines is warranted.
Related Concept Videos
00:56Viral Structure
Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
01:38Intralumenal Vesicles and Multivesicular Bodies
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
01:26Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
01:28Introduction to Virus
Viruses are unique biological entities that blur the boundary between living and non-living systems. Although they lack cellular structure and metabolic processes, they can exhibit characteristics of life when infecting a host. Their defining feature is a nucleic acid core, composed of either DNA or RNA, encapsulated within a protein coat called a capsid. This simple structure allows them to invade host cells and use their machinery for replication efficiently.Viral Structure and...
01:29Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...